Article

The Critical Role of Glutamine Transporter ASCT2 in Parkinson’s Disease Progression

2021-11-30

Abstract excerpt

<title>Abstract</title> <p>Parkinson’s Disease (PD) is the second most common neurodegenerative disease, and it plagues millions of people worldwide. PD presents with the loss of dopaminergic neurons, associated with increased oxidative stress. Glutathione (GSH) is a prominent antioxidant; in PD, however, GSH levels are significantly diminished. A precursor for GSH is the amino acid glutamine, which is converted...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2a88f988-0227-52e4-a2ec-88741cb98b4a
DOI: 10.21203/rs.3.rs-1100901/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Critical Role of Glutamine Transporter ASCT2 in Parkinson’s Disease ProgressionDOI 10.21203/rs.3.rs-1100901/v1Read

Supraphysiological glutamine as a means of depleting intracellular amino acids to enhance pancreatic cancer chemosensitivitySemantic proximity Read

Advancing Parkinson’s Disease Biopathlogy and Drug Discovery by Dual Cellular ModelingSemantic proximity Read

Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2Semantic proximity Read

Role and therapeutic targeting of glutamine metabolism in non‑small cell lung cancer (Review)Semantic proximity Read

Identification of an age-related Parkinson's disease risk factor that regulates sulfur metabolismSemantic proximity Read

Common and divergent pathways in early stages of glutamate and tau-mediated toxicities in neurodegenerationSemantic proximity Read

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosisSemantic proximity Read

Insights into the effects of alpha-synuclein expression and proteasome inhibition on glutathione metabolism through a dynamic in silico model of Parkinson's disease: validation by cell culture data.Semantic proximity Read

Mitochondrial glutamine metabolism via GOT2 supports pancreatic cancer growth through senescence inhibitionSemantic proximity Read

Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: a potential novel target in Parkinson’s disease.Semantic proximity Read

Target the human Alanine/Serine/Cysteine Transporter 2(ASCT2): Achievement and Future for Novel Cancer TherapySemantic proximity Read

Glioblastoma Sensitization to Therapeutic Effects by Glutamine Deprivation Depends on Cellular Phenotype and Metabolism.Semantic proximity Read